Can your genes predict your mental health risk?
NeuroPenetrance turns gene-expression and iPSC-derived multi-omics data into an interpretable risk signal for psychiatric and neurodevelopmental disorders — grounded in validated research from the Max Delbrück Center for Molecular Medicine, Berlin.
Six ways to go deeper
Each topic below has its own page — the problem NeuroPenetrance addresses, the science behind it, the platform itself, the validated evidence, who it serves, and who's building it.
See the signal for yourself
The proof-of-concept classification pipeline is open-source and live — trained and validated on a public whole-blood transcriptomics dataset. It's the analytical core that Engine 2 will extend to proprietary iPSC-derived data.
Open-source proof-of-concept · production clinical platform in development
Tell us who you are
A one-minute form for clinicians, researchers, pharma partners, and anyone curious — every response becomes structured customer-discovery evidence.
Let's talk about a pilot or a collaboration
- LOCATION
- Berlin, Germany
- PROOF OF CONCEPT
- neuropenetrance.streamlit.app
Send a message
This opens a pre-filled email in your mail app — nothing is stored or sent through this site.